The mechanism of TZD action is mediated largely through the activation of PPARγ, a member of the super family of ligand-activated nuclear transcription factors [42]: In the light of these cancer–specific effects, the potential use of these PPARγ agonists as chemopreventive agents has received much attention. Here, PPARG is linked to cancer.